In The News Posted March 4, 2019 Share Posted March 4, 2019 DANVILLE, Pa., March 4, 2019 /PRNewswire/ -- The National Institutes of Health has awarded researchers at Geisinger $3.1 million over the next five years to explore innovative approaches for early, genomics-based detection of arrhythmogenic right ventricular cardiomyopathy (ARVC). ARVC is ... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.